Skip to main
mason building
George Mason University

Fluidigm Biomark qPCR

Fluidigm Biomark qPCR

The Fluidigm Biomark qPCR is a system that uses microfluidics technology to process samples at nanoliter-scale volumes for gene expression, genotyping, sample identification, copy number variation analysis and digital PCR.

Location:
Institute for Advanced Biomedical Research , 3200
SciTech Campus

Contact for Scheduling:
Lance Liotta
Co-Director/Professor, Center for Applied Proteomics and Molecular Medicine (CAPMM)
lliotta@gmu.edu

Technical Specifications

Fluidigm Biomark will eliminate false positives to deliver more accurate results. All done in real-time or endpoint analysis and the capability to quantitate up to two targets per sample using multiple reporter dyes. 

* The programs and services offered by George Mason University are open to all who seek them. George Mason does not discriminate on the basis of race, color, religion, ethnic national origin (including shared ancestry and/or ethnic characteristics), sex, disability, military status (including veteran status), sexual orientation, gender identity, gender expression, age, marital status, pregnancy status, genetic information, or any other characteristic protected by law. After an initial review of its policies and practices, the university affirms its commitment to meet all federal mandates as articulated in federal law, as well as recent executive orders and federal agency directives.